An accomplished biotech executive with extensive track record in starting and growing biotech companies in the targeted immunotherapy area, based on novel technologies therapeutic products, including Founder and CEO of Adicet bio, Founding CEO of Kite Pharma (acquired by Gilead for $1.9B), CSO and SVP corporate development at Agensys and EVP and Head R&D at Astellas (acquired Agensys for $537M), Director and leader of XenoMouse technology at Cell Genesys/Abgenix (acquired by Amgen for $2.2B).